Search Results - "Stoopler, Mark B"
-
1
Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations
Published in Journal of clinical oncology (10-03-2016)“…To further understand the molecular pathogenesis of pulmonary sarcomatoid carcinoma (PSC) and develop new therapeutic strategies in this treatment-refractory…”
Get full text
Journal Article -
2
PD‐L1 expression in non‐small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens
Published in Cancer cytopathology (01-12-2017)“…BACKGROUND One immunotherapeutic agent for patients with advanced non‐small cell lung carcinoma, pembrolizumab, has a companion immunohistochemistry…”
Get full text
Journal Article -
3
Synchronous Pulmonary Adenocarcinomas
Published in American journal of clinical pathology (08-06-2020)“…Abstract Objectives To determine concordance/discordance between morphology and molecular testing (MT) among synchronous pulmonary carcinomas using targeted…”
Get full text
Journal Article -
4
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial
Published in The lancet oncology (01-06-2020)“…Approximately 25% of all patients with non-small-cell lung cancer present with resectable stage IB–IIIA disease, and although perioperative chemotherapy is the…”
Get full text
Journal Article -
5
Histologic Assessment of Non–Small Cell Lung Carcinoma after Neoadjuvant Therapy
Published in Modern pathology (01-11-2003)“…Chemotherapy or chemoradiation is often used in Stage IIIA non–small cell lung carcinoma before surgical resection (neoadjuvant therapy). In reviewing the…”
Get full text
Journal Article -
6
Synchronous Pulmonary Adenocarcinomas: Correlation Among Morphology, Next-Generation Sequencing/Single-Gene Analysis Molecular Testing, and Clinical Outcomes With Eighth Edition AJCC Criteria
Published in American journal of clinical pathology (01-07-2020)“…Objectives: To determine concordance/discordance between morphology and molecular testing (MT) among synchronous pulmonary carcinomas using targeted next…”
Get full text
Journal Article -
7
Effects of β-Adrenergic Antagonists on Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Published in Journal of clinical medicine (26-04-2019)“…Locally advanced non-small cell lung cancer (NSCLC) is highly resistant to chemoradiotherapy, and many cancer patients experience chronic stress. Studies that…”
Get full text
Journal Article -
8
Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?
Published in Neuro-oncology (Charlottesville, Va.) (01-07-2015)“…We investigated effects of genetic alterations in epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and Kirsten rat sarcoma viral…”
Get full text
Journal Article -
9
Characteristics and outcomes of lung cancer in solid organ transplant recipients
Published in Lung cancer (Amsterdam, Netherlands) (01-08-2020)“…•Transplant patients are likely to be diagnosed at advanced stages of lung cancer.•Squamous cell carcinoma is more commonly diagnosed in transplant…”
Get full text
Journal Article